Search
for
Sort by
Research 31–60 of 251
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- The immune response to COVID‐19: Does sex matter?
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Polymorphism of genes in patients with new coronavirus infection COVID-19
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- It’s X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men
- Skin amidst COVID ‐19 pandemic
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Sex Hormones in COVID-19 Severity: The Quest for Evidence and Influence Mechanisms
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- ANDROGENŲ IR ANDROGENINĖS ALOPECIJOS RYŠYS SU COVID-19 INFEKCIJA
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Alopecia androgênica como agravo da infecção por SARS-CoV-2
- The role of testosterone in SARS-CoV-2 infection
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- SARS‐CoV‐2 & androgenic alopecia: exploring links!
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- Human genetic basis of coronavirus disease 2019
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Candidate genes of SARS-CoV-2 gender susceptibility
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Host Genetic Susceptibility and Impacts of Dietary Factors on Covid-19